US · Healthcare · Health Information Services
EPS came in at 0.70 against a street estimate of 0.31 — a beat of 125.8%.
Analysts rate Omnicell Inc a buy (4 buy, 4 hold, 0 sell out of 8) with an average price target of $57.86.
MIXED Strong Q2 beat on profitability ($0.94 EPS vs. $0.31 guide), but management widened full-year bookings range to $425–$560M, citing unpredictable enterprise deal timing. Titan XT early-stage traction and cloud platform OmniSphere remain on track. Q2 2026 Connected devices portfolio performing steadily across both North America and international markets. No region-specific breakdowns provided. Analysts probed the stark bookings range widening and competitive deal-timing extension. Management attributed both to multi-stakeholder enterprise sales cycles and simultaneous new-platform launches by both major competitors, not demand weakness. Emphasized pipeline strength and confidence in long-term opportunity. 2026-07-30…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.80% |
| Vanguard Portfolio Management, LLC | 7.05% |
| Wellington Management Company LLP | 5.92% |
| Dimensional Fund Advisors, Inc. | 5.38% |
| State Street Corp | 4.28% |
| Vanguard Capital Management, LLC | 4.24% |
| Millennium Management LLC | 3.80% |
| Delaware Management Holdings Inc | 2.59% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 OMNICELL, INC. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues (6M 2026): $622,088 thousand ($622.1 million), up from $560,230 thousand in | 2026-08-05 |
| Results announced · Q3 2026 OMNICELL, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Report Date: July 30, 2026 for quarter ended June 30, 2026 (Q2 2026) • Company: Omnicell, Inc. | 2026-07-30 |
| Board / officer change · Q2 2026 OMNICELL, INC. - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Nnamdi Njoku appointed President of Omnicell, effective July 1, 2026, while retain | 2026-07-01 |
| Board / officer change · Q2 2026 OMNICELL, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 19, 2026 • 1,600,000 additional shares authorized under equity incentiv | 2026-05-26 |
| Quarterly report · Q1 2026 OMNICELL, INC. — Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Q1 2026 Total Revenues: $309.9 million (up from $269.7 million in Q1 2025, +14.9% grow | 2026-05-06 |
| Results announced · Q2 2026 OMNICELL, INC. - Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Total revenues Q1 2026: $310 million, up $40 million or 15% year-over-year from $270 m | 2026-04-28 |
| Proxy statement · Q2 2026 OMNICELL, INC. – 2026 PROXY STATEMENT SUMMARY --- CEO COMPENSATION • Total 2025 compensation for CEO: Not explicitly stated in provided text; detai | 2026-04-13 |
| Annual report FY2025 OMNICELL, INC. — FORM 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Public Company Status: Large accelerated filer on NASDAQ (ticker: OMCL), | 2026-02-26 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Omnicell Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.